Ochsner Health

Ochsner Health

Ochsner Health was founded in 1942 and has since grown into the dominant nonprofit health system across Louisiana, Mississippi, and the Gulf South. The organization’s economic base is a network of 47 hospitals and over 370 health and urgent care centers, anchored by the flagship Ochsner Medical Center in New Orleans, which has held the U.S. News & World Report designation as the Best Hospital in Louisiana for 14 consecutive years. The system deploys capital across a deliberately broad asset-class mix: direct hospital acquisitions, commercial real estate holdings including Benson Tower and multiple campus expansions, and venture-stage investments through Ochsner Ventures. Its clinical partnership with MD Anderson Cancer Center operates cancer care across Louisiana, while the new Xavier Ochsner College of Medicine — launched in partnership with Xavier University of Louisiana — represents a direct investment in physician-pipeline infrastructure. Ochsner Ventures, the system’s innovation arm, pursues buyout and growth-equity deals in digital health and care-delivery technology, making the organization both a healthcare provider and an active investor in the tools reshaping its own operations. With more than 40,000 team members and 4,900 employed and affiliated physicians, Ochsner provides care to 1.6 million patients annually from every U.S. state and 63 countries. The organization maintains the Ochsner Health Foundation as its primary philanthropic vehicle and operates one of the largest permanent art collections integrated into a clinical care setting. In early 2024, Ochsner Medical Center – New Orleans received its fifth Magnet Recognition for nursing excellence, a distinction held by fewer than 1% of hospitals nationally — the most recent in a multi-decade pattern of reinvestment into clinical quality infrastructure. What structurally distinguishes Ochsner from a typical nonprofit health system is its hybrid posture: it functions as a direct operator of care delivery, an asset owner with a substantial real estate portfolio, and a limited partner in its own future through Ochsner Ventures’ technology investments. This operating-company relationship to venture capital means deal flow emerges from clinical need rather than from fund-marketing calendars, creating a sourcing model that is difficult for outside managers to replicate.